483 related articles for article (PubMed ID: 16273188)
1. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
[TBL] [Abstract][Full Text] [Related]
3. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
4. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
Prasad AR; Savera AT; Gown AM; Zarbo RJ
Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
[TBL] [Abstract][Full Text] [Related]
6. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues.
Bilal H; Handra-Luca A; Bertrand JC; Fouret PJ
J Histochem Cytochem; 2003 Feb; 51(2):133-9. PubMed ID: 12533521
[TBL] [Abstract][Full Text] [Related]
7. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells.
Boecker W; Stenman G; Loening T; Andersson MK; Berg T; Lange A; Bankfalvi A; Samoilova V; Tiemann K; Buchwalow I
Virchows Arch; 2015 Jan; 466(1):21-36. PubMed ID: 25344874
[TBL] [Abstract][Full Text] [Related]
8. Comparison of p63 and p73 expression in benign and malignant salivary gland lesions.
Seethala RR; LiVolsi VA; Zhang PJ; Pasha TL; Baloch ZW
Head Neck; 2005 Aug; 27(8):696-702. PubMed ID: 16021638
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands.
Genelhu MC; Gobbi H; Soares FA; Campos AH; Ribeiro CA; Cassali GD
Oral Oncol; 2006 Feb; 42(2):154-60. PubMed ID: 16256413
[TBL] [Abstract][Full Text] [Related]
10. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases.
Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S
Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488
[TBL] [Abstract][Full Text] [Related]
12. K5/K14-positive cells contribute to salivary gland-like breast tumors with myoepithelial differentiation.
Boecker W; Stenman G; Loening T; Andersson MK; Bankfalvi A; von Holstein S; Heegaard S; Lange A; Berg T; Samoilova V; Tiemann K; Buchwalow I
Mod Pathol; 2013 Aug; 26(8):1086-100. PubMed ID: 23558567
[TBL] [Abstract][Full Text] [Related]
13. [Expression of deltaNp63 in salivary gland tumours].
He ZX; Li YN; Liu LK; He HW; Wang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):126-8. PubMed ID: 16468660
[TBL] [Abstract][Full Text] [Related]
14. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin and E-cadherin expression in salivary gland tumors.
Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
[TBL] [Abstract][Full Text] [Related]
16. [Myoepithelial differentiation markers in salivary gland neoplasia].
Scarpellini F; Marucci G; Foschini MP
Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
18. Vimentin as a marker of myoepithelial cells in salivary gland tumors.
de Araújo VC; de Araújo NS
Eur Arch Otorhinolaryngol; 1990; 247(4):252-5. PubMed ID: 2165413
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
Safoura S; Mohamad E; Nosrat-Allah E; Fereshte E
J Cancer Res Ther; 2011; 7(1):23-8. PubMed ID: 21546738
[TBL] [Abstract][Full Text] [Related]
20. WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium.
Langman G; Andrews CL; Weissferdt A
Mod Pathol; 2011 Feb; 24(2):168-74. PubMed ID: 21057459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
